Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00075829 · OUTCOME

Overall Survival (OS) for High Risk

Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) · Source last updated 2021-11-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
Year 3

What was measured

The event is death from any cause, patients alive at the time of last observation are considered censored.

Analysis population: Patients that completed second transplant

Groups in this outcome

Auto-Auto High Risk

Tandem autologous transplant plus thalidomide/dexamethasone or observation for high risk patients

Auto-Allo High Risk

Autologous transplant plus non-myeloablative allogeneic transplant for high risk patients

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Auto-Auto High Risk31
Auto-Allo High Risk29

Reported measurements

Source class 1
Values in percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Auto-Auto High Risk67Not reported5482Not reported
Auto-Allo High Risk59Not reported4578Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        54
        upper Limit
        82
        value
        67
      2. group Id
        OG001
        lower Limit
        45
        upper Limit
        78
        value
        59
denoms
  1. counts
    1. group Id
      OG000
      value
      31
    2. group Id
      OG001
      value
      29
    units
    Participants
description
The event is death from any cause, patients alive at the time of last observation are considered censored.
dispersion Type
95% Confidence Interval
groups
  1. description
    Tandem autologous transplant plus thalidomide/dexamethasone or observation for high risk patients
    id
    OG000
    title
    Auto-Auto High Risk
  2. description
    Autologous transplant plus non-myeloablative allogeneic transplant for high risk patients
    id
    OG001
    title
    Auto-Allo High Risk
param Type
NUMBER
population Description
Patients that completed second transplant
reporting Status
POSTED
time Frame
Year 3
title
Overall Survival (OS) for High Risk
type
SECONDARY
unit Of Measure
percentage of participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice